European Research Ranking
Home
Methods
Rankings
Institutions
Countries
Updates
Search
Feedback
Projects
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- France
Project overview (since 2010-01-01):
<< previous
next >>
Start date
Project
acronym
role
funding
partners
2018-01-01
The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients
EU-TRAIN
participant
6.641.546
13
2018-01-01
Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative
R-LiNK
participant
7.702.532
22
2018-01-01
Immune Signatures for Therapy Stratification in Major Mood Disorders
MOODSTRATIFICATION
participant
5.963.750
12
2017-12-01
Repurposing of carbamazepine for treatment of skeletal dysplasia
MCDS-Therapy
participant
5.697.391
10
2017-11-01
Liver Investigation: Testing Marker Utility in Steatohepatitis
LITMUS
participant
15.797.881
56
2017-09-01
Targeting the metabolism-immune system connections in Cancer
META-CAN
participant
3.831.958
20
2017-09-01
An INtegrated next generation PREParedness programme for improving effective inter-organisational response capacity in complex environments of disasters and causes of crises
IN-PREP
participant
7.999.556
20
2017-06-01
PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088
PEVIA
coordinator
6.189.570
14
2017-01-01
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
HARMONY
participant
20.200.000
53
2017-01-01
3-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration
ArrestAD
participant
3.991.096
8
2017-01-01
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection
HIVACAR
participant
6.685.111
15
2017-01-01
Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)
ALIVER
participant
6.478.738
11
2017-01-01
REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy
RESPINE
participant
5.555.836
15
2017-01-01
HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making
HarmonicSS
participant
9.998.750
39
2017-01-01
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
LIVERHOPE
participant
5.998.800
18
2016-10-01
Expanding and extending gene therapy of monogenic diseases of the haematopoietic system
GENE FOR CURE
participant
2.445.268
2
2016-02-01
Decision Support and Information Management System for Breast Cancer
DESIREE
participant
3.340.720
12
2016-01-01
Imaging the Force of Cancer
FORCE
participant
5.812.631
16
2015-11-01
EVA - patient ventilation beyond limits
EVA
participant
1.890.000
5
2015-10-01
Innovative training network: Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura
PROFILE
participant
1.464.398
9
2015-09-01
REgenerative Stem cell therapy for STroke in Europe
RESSTORE
participant
6.338.259
31
2015-05-01
Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.
CARBALIVE
participant
5.913.080
14
2015-05-01
I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly
I-MOVE-plus
participant
7.482.729
25
2015-05-01
A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly
EU-CaRE
participant
5.593.049
10
2015-05-01
Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension
ENSAT-HT
participant
7.607.337
13
2015-01-01
Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis
ADIPOA2
participant
5.999.000
18
2014-11-01
Prevention and Management of High Threat Pathogen Incidents in Transport Hubs
PANDHUB
participant
3.142.004
6
2014-04-01
Mimimally invasive retrograde targeting of aCAR lentiviral vector to non-human primate motor neurons
RTLVNHP
participant
149.526
2
2014-01-01
Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics
Lab2Go
participant
1.915.000
10
2014-01-01
Tissue engineering of the right heart outflow tract by a biofunctionalized bioresorbable polymeric valved tube
TEH-TUBE
coordinator
4.500.962
7
2013-12-01
A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
MERCURIC
participant
5.999.995
13
2013-10-01
A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer
GANNET53
participant
5.994.072
18
2013-10-01
Collaborative European NeuroTrauma Effectiveness Research in TBI
CENTER-TBI
participant
29.998.903
38
2013-10-01
Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified.
CFMATTERS
participant
5.999.748
12
2013-09-01
Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock
CULPRIT-SHOCK
participant
5.999.145
17
2013-09-01
Semantics-driven Design through Geo and Building Information Modelling for Energy-efficient Buildings Integrated in Mixed-use Healthcare Districts
STREAMER
participant
8.000.000
20
2013-07-01
GAbapentin in Paediatric Pain
GAPP
participant
5.476.875
15
2013-03-01
Biomarkers of renal graft injuries in kidney allograft recipients
BIOMARGIN
participant
6.000.000
13
2013-02-01
Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility
NANOATHERO
participant
9.833.348
16
2013-01-01
Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
EUROFANCOLEN
participant
5.380.170
11
2012-12-01
Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)
NET4CGD
participant
5.999.607
11
2012-12-01
A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches
EUROSTAM
participant
2.623.500
11
2012-11-01
"Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration"
OPTIMISTIC
participant
3.000.000
9
2012-11-01
Clinical Development of Nitisinone for Alkaptonuria
DEVELOPAKURE
participant
5.999.999
13
2012-11-01
Metagenomics in Cardiometabolic Diseases
METACARDIS
participant
11.999.992
15
2012-10-01
Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD)
DSD-LIFE
participant
2.999.956
16
2012-10-01
European Consortium for High-Throughput Research in Rare Kidney Diseases
EURENOMICS
participant
11.994.567
28
2012-10-01
Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes
DIABIL-2
coordinator
5.900.000
6
2012-07-01
Rapid Identification of Respiratory Tract Infections
RID-RTI
participant
5.997.737
6
2012-03-01
European Consortium for the Early Treatment of Diabetic Retinopathy
EUROCONDOR
participant
5.998.762
18
<< previous
next >>